Partner with us
Evidence-based solutions designed to improve health knowledge and decision making
About us
20 years of experience helping Australians make better health decisions
NPS MedicineWise was established in 1998 as the National Prescribing Service (NPS) Limited. Through two decades of continuous national leadership and services provided in the health sector, NPS MedicineWise remains committed to supporting quality use of medicines to improve health decisions and health and economic outcomes in Australia.
Our philosophy
Independent. Not-for-profit. Evidence-based. Consumer-centred.
Our vision
Improve the health of Australians.
Our mission
Improve health through safe and wise use of medicines and other health technologies.
Improving health decisions and outcomes
Established in 1998 with the primary aim of promoting quality use of medicines, today we have grown to connect with health consumers and health professionals nation-wide, changing attitudes and behaviours, and empowering all Australians to make the best possible healthcare decisions when they count.
Reconciliation - coming together
NPS MedicineWise is committed to reconciliation with Aboriginal and Torres Strait Islander people.
To help us deliver on that commitment, we have a Reconciliation Action Plan (RAP), endorsed by Reconciliation Australia. Our RAP is currently being updated. The RAP outlines actions, responsibilities, targets and timelines across a range of themes for achieving our vision of reconciliation, and offers opportunities for everyone across NPS MedicineWise to get involved.
NPS MedicineWise organisational strategy 2020-2022
Our vision is to improve the health of Australians.
Our mission is to improve health through safe and wise use of medicines and other health technologies.
We add value as the steward of quality use of medicines: promoting safe and wise use of medicines; bridging gaps between evidence and practice; and enabling better decisions.
We aim to:
- Improve the use of medicines and other health technologies to optimise health outcomes for Australians
- Improve health literacy of Australians
- Reduce misuse of medicines and other health technologies
- Improve the sustainability of the Pharmaceutical Benefits Scheme and Medical Benefits Scheme.
Our focus over the next two years is to:
- Improve health outcomes for Australians
- Be a sustainable, high impact organisation
We will achieve this by focusing on five priorities:
1. Drive strong national stewardship of quality use of medicines
2. Target quality use of medicines where the need or opportunity is greatest
3. Optimise the use of health insights
4. Improve our accountability, effectiveness and efficiency
5. Strengthen our financial sustainability
Delivering on Australia’s quality use of medicines priorities
As the national steward for quality use of medicines and medical tests (generally abbreviated as QUM) in Australia, NPS MedicineWise delivers programs and services that deliver on the QUM objectives of Australia’s National Medicines Policy.
Ultimately, we seek to improve the health of Australians through the safe and wise use of medicines and health technologies by building the health literacy of Australians and improving use of medicines and other health technologies while contributing to the sustainability of our health system.
Our Quality Use of Medicines (QUM) Grant
Value in Prescribing Grants
Biologic disease-modifying anti-rheumatic drugs (bDMARDs)
NPS MedicineWise leads a consortium of health organisations funded under the Australian Government’s Value in Prescribing Program to collaboratively improve the use of bDMARDs, support specialist prescribers and help consumers get the most benefit from these complex medicines.
Read more about the consortium and our approach to supporting specialist prescribing of bDMARDs.
Immunoglobulin products
Under the Australian Government’s Value in Prescribing Program, NPS MedicineWise and a consortium of health organisations is working nationally to improve health outcomes for patients prescribed immunoglobulin products.
We are working with the National Blood Authority and a range of stakeholders to develop and deliver educational resources, tools and interventions to support clinicians in optimising the use of precious immunoglobulin products, as well educate consumers on these products.
Read more about how we are supporting the best use of precious immunoglobulin products.
Partner with us
We offer evidence-based solutions designed to improve health knowledge and decision making.
Our team of experts is specialised in structuring and co-designing programs and products to meet different health research, policy making, health system and primary care needs.